ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.1392
-0.08%
Brent Oil
85.625
-0.31%
Bitcoin
60,289.99
-0.51%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Rhythm Pharmaceuticals Inc (RYTM)

  7. Rhythm Pharmaceuticals Inc (RYTM) Noticias

RYTM Rhythm Pharmaceuticals Inc

39.76
0.94 (2.42%)
30 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Rhythm Pharmaceuticals Inc RYTM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.94 2.42% 39.76 18:32:16
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
38.39 37.60 41.27 39.76 38.82
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202417:30GLOBERhythm Pharmaceuticals Announces Publication of Results from..
24/4/202415:01GLOBERhythm Pharmaceuticals to Report First Quarter 2024..
16/4/202415:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
01/4/202407:00GLOBERhythm Pharmaceuticals Secures $150 Million in Convertible..
25/3/202407:00GLOBERhythm Pharmaceuticals Announces First Patient Dosed in..
11/3/202415:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
06/3/202415:01GLOBERhythm Pharmaceuticals Announces Participation at Upcoming..
29/2/202415:58EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202415:46EDGAR2Form 8-K - Current report
29/2/202415:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202415:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202406:01EDGAR2Form 8-K - Current report
22/2/202406:01GLOBERhythm Pharmaceuticals Announces Clinical Development Plan..
22/2/202406:00GLOBERhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial..
21/2/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202417:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:19EDGAR2Form 144 - Report of proposed sale of securities
08/2/202415:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
07/2/202407:00GLOBERhythm Pharmaceuticals Announces Positive Reimbursement..
05/2/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202417:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202417:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202407:00GLOBERhythm Pharmaceuticals to Report Fourth Quarter and Full..
12/1/202415:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
04/1/202406:15EDGAR2Form 8-K - Current report
04/1/202406:00EDGAR2Form 8-K - Current report
04/1/202406:00GLOBERhythm Pharmaceuticals and LG Chem Life Sciences Enter..
04/1/202405:58GLOBERhythm Pharmaceuticals Announces Completion of Screening for..
29/12/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202315:22EDGAR2Form 144 - Report of proposed sale of securities
18/12/202315:16EDGAR2Form 8-K - Current report
15/12/202315:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
13/12/202306:00GLOBERhythm Pharmaceuticals Sponsors Second Annual International..
06/12/202315:30EDGAR2Form 8-K - Current report
06/12/202306:00GLOBERhythm Pharmaceuticals Announces Updates on MC4R Pathway..
16/11/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202316:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
09/11/202315:14EDGAR2Form 144 - Report of proposed sale of securities
08/11/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:14EDGAR2Form 144 - Report of proposed sale of securities
07/11/202317:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
RYTM
Rhythm Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados